PerkinElmer
check quantity

IVISense Bacterial 750 Fluorescent Probe in RediJect Solution (1 vial) (XenoLight)

IVISense Bacterial 750 (XenoLight Rediject Bacterial Detection) fluorescent probe is a near-infrared (NIR) fluorescent probe for in vivo targeting of both gram positive and gram negative bacterial infections.

IVISense Bacterial 750 probes are available in either 1 or 4 vial quantities in a convenient, ready-to-use injectable format.

For research use only. Not for use in diagnostic procedures.

Part Number
SKU Display Name
List Price
Your Price
Quantity
133397
IVISense Bacterial 750 Fluorescent Probe in RediJect Solution (1 vial) (XenoLight)
167.00 USD
 
more
133398
IVISense Bacterial 750 Fluorescent Probe in RediJect Solution (4 vials) (XenoLight)
532.00 USD
 
more
133399
IVISense Bacterial 750 Fluorescent Control Dye in RediJect Solution (1 vial) (XenoLight)
166.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

IVISense Bacterial 750 fluorescent probe in RediJect solution, specifically targets the anionic phospholipids of bacterial cell membrane, and so targets gram-negative bacteria slightly more efficiently than gram-positive bacteria. This fluorescent agent is extremely bright, allowing sensitive detection of deep-tissue infections caused by a range of bacteria.

IVISense Bacterial 750 fluorescent probe in RediJect Solution (1 vial):

  • Novel ready-to-use probe for in vitro and in vivo detection of bacterial infections
  • Dispensed to image 5 mice (based on 30g/mouse)
  • Visualize, quantify, and track bacterial infection longitudinally and non-invasively
  • in vivo imaging quality, validated on our industry-leading IVIS® optical imaging systems

Specifications

Fluorescent Agent Type Targeted
Optical Imaging Classification Fluorescence Imaging
Product Brand Name IVISense
Quantity in a Package Amount 5.0 Units
Shipping Condition Blue Ice
Therapeutic Area Bacterial infection
Unit Size 1 Kit (5 animals)
Wave Length 750 nm
Resources, Events & More
  • All

Ebook

In Vivo Imaging Solutions eBook

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And our hard-earned expertise makes us a trusted provider of pre-clinical imaging solutions— with more than 9,000 peer reviewed articles as proof.

PDF 4 MB

Flyer

Best Practices for Designing An Effective In Vivo Fluorescence Imaging Study

Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into disease processes and treatment effects. Designing an effective study from the beginning can help save time and resources.

Learn about several important best practices, from proper probe selection to study design to imaging technique tips and tricks needed to generate meaningful biological information from your in vivo fluorescence imaging studies.

PDF 507 KB
XenoLight RediJect Bacterial Detection Probe 750 (Product Sheet)

XenoLight RediJect Bacterial Detection Probe is a Near Infrared,(NIR) fluorescent agent for in vivo targeting of both gram positive and,gram negative bacterial infections. This probe specifically targets the,anionic phospholipids of bacterial cell membrane, and so targets gram,negative bacteria slightly more efficiently than gram positive bacteria.,RediJect bacterial detection probe is extremely bright, allowing sensitive,detection of deep-tissue infections caused by a range of bacteria,including Staphylococcus aureus, Streptococcus pneumoniae,Pseudomonas aeruginosa, Salmonella typhimurium and Escherichia coli.

PDF 1 MB

White Paper

The Role of In Vivo Imaging in Drug Discovery and Development

The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick and efficient drug screening and evaluation. Read this White Paper to learn how preclinical in vivo imaging helps to ensure that smart choices are made by providing Go/No-Go decisions and de-risking drug candidates early on, significantly reducing time to the clinic and lowering costs all while maximizing biological understanding.

PDF 547 KB